Passer au contenu Aller au pied de page
Advair Diskus 250/50: Benefits, Reviews, Info, Side Effects!
Détails de la prescription
Advair Diskus 250/50
Seretide, Viani, Breva
Fluticasone propionate/salmeterol
Médicament
Médicaments
Sur ordonnance uniquement
maintenance treatment of asthma, improvement of lung function, reduction of asthma symptoms, prevention of asthma exacerbations, management of chronic obstructive pulmonary disease (COPD), reduction of COPD flare-ups, improvement of breathing, long-term control of respiratory conditions
Bone Pain, Bronchitis, Cough, Dizziness, Headache, Hoarseness, Muscle Pain, Nausea, Pneumonia, Sinusitis, Throat Irritation, Upper Respiratory Tract Infection, Voice Changes, Vomiting
Advair Diskus 250/50 is a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: fluticasone propionate (250 micrograms) and salmeterol (50 micrograms). The typical dosage for Advair Diskus 250/50 is one inhalation twice daily, approximately 12 hours apart. However, the exact dosage and frequency should be determined by a healthcare provider based on the individual’s specific condition and response to treatment. Always follow the prescribing doctor’s instructions and the guidance provided with the medication.
Asthme, bronchopneumopathie chronique obstructive
Common side effects of Advair Diskus 250/50 include headache, throat irritation, and upper respiratory tract infection.
Aucune interaction signalée
$40,000.00

Un résumé de

Advair Diskus 250/50

Advair Diskus 250/50 is a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: fluticasone, a corticosteroid that reduces inflammation in the airways, and salmeterol, a long-acting beta agonist that helps to relax the muscles in the airways, making it easier to breathe.

This combination medication is typically used as a maintenance treatment to prevent asthma attacks or COPD exacerbations. It is not a rescue inhaler and should not be used to treat sudden breathing problems. Advair Diskus 250/50 is intended for long-term use and should be taken regularly as prescribed by your healthcare provider.

It is important to follow the instructions for using the Advair Diskus device carefully to ensure that you are getting the correct dose of medication. This may involve inhaling the medication in a specific way or cleaning the device regularly to prevent blockages.

As with any medication, Advair Diskus 250/50 may cause side effects in some individuals. Common side effects may include headache, throat irritation, and hoarseness. More serious side effects such as increased heart rate, chest pain, or worsening breathing problems should be reported to your healthcare provider immediately.

Before starting Advair Diskus 250/50, be sure to inform your healthcare provider of any other medical conditions you may have, as well as any other medications or supplements you are taking. They can help determine if this medication is right for you and adjust your treatment plan accordingly.

Overall, Advair Diskus 250/50 can be an effective treatment option for managing asthma or COPD symptoms when used as directed by your healthcare provider. If you have any questions or concerns about this medication, do not hesitate to discuss them with your healthcare provider.

Avis de non-responsabilité juridique de RxDb

Les informations fournies sur RxDB.net sont fournies à titre informatif uniquement et ne sont pas destinées à remplacer un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours un professionnel de la santé qualifié, tel qu'un médecin ou un pharmacien, pour toute question ou préoccupation concernant votre santé, vos médicaments ou votre état de santé. Vous vous fiez entièrement aux informations fournies sur ce site Web à vos propres risques. RxDB.net ne fournit pas de services médicaux ou pharmaceutiques et n'est pas responsable des décisions prises sur la base des informations contenues dans le présent document.

DERNIÈRE MISE À JOUR DE LA PAGE

0
J'aimerais connaître votre avis, n'hésitez pas à commenter.x
fr_CAFR